Delivery Order SPE2DB22D9239-SPE2DB24FDK21
Award Date 6/6/24
Potential Completion Date 6/28/24
Potential Value $109K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $72,848.30, is for the delivery of XENPOZYME 20 MG VIALS. This order is issued under a larger indefinite delivery contract (IDC) valued at up to $499,999,999 with the DLA, which allows the agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $87,418.08 firm fixed-price contract is for the delivery of XENPOZYME 20 MG VIALS, with a completion date of June 11, 2025. The contract is not set aside for any specific business category. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $109,272.60 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of XENPOZYME 20 MG VIALS, a specialized pharmaceutical product, with a period of performance through November 6, 2024. DMS Pharmaceutical Group is a key supplier for the DLA, holding a $499,999,999 Indefinite Delivery Contract to...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The $145,696.80 award is for the delivery of XENPOZYME 20 MG VIALS, a pharmaceutical product, with a completion date of January 17, 2025. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue firm...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $109,272.60 contract is for the supply of XENPOZYME 20 MG VIALS, a pharmaceutical product, with a period of performance through August 30, 2024. The award is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group valued at up to $499,999,999, which runs through...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $109,272.60 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of XENPOZYME 20 MG VIALS and has an ultimate completion date of April 15, 2024. This delivery order is placed under DMS Pharmaceutical Group's existing indefinite delivery contract with DLA, contract 4600082013 under the SPE2DB program, which is valued at up...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $90,227.44 award is for the supply of 4560051450 - XENPOZYME 20 MG VIALS to support the recurring medical supply needs of military healthcare facilities. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business based in Park Ridge, Illinois. The contract, valued at $109,272.60, is for the delivery of XENPOZYME 20 MG VIALS, a pharmaceutical product. The order has an ultimate completion date of March 29, 2024 and is not set aside for any specific business category. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract,...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of XENPOZYME 20 MG VIALS, a medical product, with a ceiling value of $87,418.08 and a period of performance through July 25, 2025. DMS Pharmaceutical Group has a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the...
- This is a federal contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $109,272.60, is for the delivery of XENPOZYME 20 MG VIALS, identified by the product code 4564530130. The contract has a firm fixed-price delivery order type and an ultimate completion date of May 16, 2024. This award is associated with a larger indefinite delivery contract (IDC)...
- SPE2DB22D9239Indefinite Delivery Contract
- SPE2DB22D9239-SPE2DB24FDK21Delivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $109,272.60 firm fixed-price contract is for the supply of XENPOZYME 20 MG VIALS, a pharmaceutical product. The award falls under a larger indefinite delivery contract (IDC) that DMS Pharmaceutical Group holds with the DLA, valued at up to $499,999,999, to provide a comprehensive range of pharmaceutical items to military health facilities worldwide. This IDC, under the SPE2DB program, allows the DLA to issue delivery orders for recurring medical supply needs. The contract does not have a set-aside designation.
Generated 9/5/24, 9:46 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $109.3k | 6/6/24 |